It’s worth noting that diabetic individuals with factors such as a high bacterial load, reduced effective drug concentrations of anti-tuberculosis medications, compromised host immune responses, and decreased levels of IFN-γ and IL-12 can be more susceptible to Mycobacterium tuberculosis (MTB) infection and at a heightened risk of drug resistance [16]. This evidence concerns the gene IFNG and tuberculosis.